49.8200.54% ( +0.270 )
Delay Trading: Oct 27, 10:14:44 (EDT)Current ValuationThe current P/E ratio is 64.99, above the reasonable range, cheaper than 1.79% of the time in the past 3 years, and the industry ranks 41/173, the industry Median -0.80.
64.99xP/E
$49.55Stock price
$0.76Earnings per share
64.99xP/E
Stock price$49.55Earnings per share$0.76
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- 50.85x
- Typical range
- 44.83x–57.19x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
017345168
The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
| Name/Symbol | |||
|---|---|---|---|
CHEOYUSCochlear Limited | 64.99x | -- | $6.48B |
IARTUSIntegra LifeSciences | 72.37x | 107.27% | $941.70M |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
